Corporate News-Good Doctor

Blog

——

2026.07.13

Good Doctor·Hyperthermic Perfusion | Literature Review and Analysis | (6) “Clinical Study on the Treatment of Advanced Gastric Cancer with Ascites Using Hyperthermic Intraperitoneal Chemotherapy”

Hyperthermic intraperitoneal chemotherapy demonstrates definitive efficacy in treating malignant ascites secondary to gastric cancer, while also improving patients’ quality of life and exhibiting a low incidence of adverse events, making it worthy of clinical adoption and broader application.

2026.07.10

Building on Standards, Achieving Long-Term Success Through Collaboration—A New Chapter in the Diagnosis and Treatment of Peritoneal Tumors Begins

On July 2, 2026, the Inauguration Ceremony of the Peritoneal Cancer Prevention and Treatment Research Center of the Clinical Medical College of Tsinghua University, the Appointment Ceremony for International Experts in Peritoneal Tumors, and the Launch Meeting for Clinical Diagnosis and Treatment Standards for Pseudomyxoma Peritonei were held at Peking Union Medical College Hospital—Tsinghua University. Experts and scholars from both China and abroad attended, engaging in in-depth discussions on collaborative innovation in peritoneal cancer prevention and treatment, standardized diagnosis and management of pseudomyxoma peritonei, and the development of group standards.

2026.07.10

Good Doctor·Hyperthermic Perfusion | Literature Review and Analysis | (5) “An Experimental Study on the Safety of Hyperthermic Perfusion Chemotherapy in Body Cavity Circulation”

This study investigated the effects of different temperatures during hyperthermic intraperitoneal chemotherapy (HIPEC) on the vital signs and intra-abdominal organs of experimental dogs, with the aim of determining the optimal temperature for HIPEC in this animal model. The results demonstrated that a temperature range of 42°C to 42.5°C is therapeutically appropriate, and that therapeutic efficacy is achieved only when the intraperitoneal temperature reaches 42.5°C.

2026.06.28

Good Doctor·Hyperthermic Perfusion | Literature Review and Analysis | (4) “Clinical Application of Early Postoperative Intraperitoneal Hyperthermic Perfusion Chemotherapy for Gastric Cancer”

Hyperthermic perfusion therapy equipment: TRL-type thermochemotherapy perfusion machine (produced by Harbin Aerospace Science and Technology Development Co., Ltd., the predecessor of Xi’an Good Doctor Medical Science and Technology Co., Ltd.).

2026.06.27

Good Doctor·Hyperthermic Perfusion | Literature Review and Analysis | (3) “A Controlled Study of Intracavitary Constant-Temperature Circulating Hyperthermic Perfusion Chemotherapy for Malignant Pleural Effusion”

Case selection: The observation group comprised 25 patients aged 39–65 years, including 18 cases of lung cancer, 5 cases of pleural mesothelioma, and 2 cases of breast cancer; 15 were male and 10 were female.

2026.06.05

Good Doctor · Hyperthermic Perfusion | Exploring the Microscopic World of “Hyperthermic Perfusion”

Good Doctor·Thermal Perfusion, deeply focused on clinical details, scientifically selects the perfusion solution to ensure the efficacy of perfusion therapy.

2026.05.14

Good Doctor・Hyperthermic Intraperitoneal Chemotherapy (GDHIPEC) | Versatile Clinical Applications to Meet Diverse Diagnostic and Therapeutic Needs

The multi‑scenario adaptability of the intracavitary hyperthermic perfusion therapy machine is a crucial support for standardized, comprehensive cancer care. As one of the cutting‑edge devices in clinical oncology, the Xi’an Good Doctor Intracavitary Hyperthermic Perfusion Therapy Machine (GDHIPEC) is compatible with preoperative, intraoperative, and postoperative adjuvant therapies, and can be applied across multiple departments for palliative treatment. It covers various body cavities, including the abdominal and thoracic cavities, and is suitable for treating cancers of the gastrointestinal, gynecological, hepatobiliary, urological, and thoracic systems. Moreover, it enables dual‑mode hyperthermic perfusion—both with and without fluid—for tumors involving the pleura and peritoneum, truly achieving full coverage across departments and disease stages with a single device. This helps hospitals establish a standardized system for the prevention and treatment of intracavitary tumors, balancing clinical efficacy, patient benefits, and the practical value of the equipment.

2026.05.06

Good Doctor·Hyperthermic Perfusion | Bringing the “Effective Treatment Temperature” Truly into Hyperthermia Clinical Practice

< 1 2 3 4 5 6 > proceed page

· GDHIPEC from China ,

· Caring for Patients Worldwide ·

Tel.: +86 29 82681864

Sales service hotline: +86 15002902555

E-mail: gd029@126.com

Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143

Blog

COOKIES

COOKIES

Sorry，The current column has no content!